E Panak

5.0k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

E Panak is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, E Panak has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 2 papers in Pharmacology. Recurrent topics in E Panak's work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Lipoproteins and Cardiovascular Health (3 papers) and Meta-analysis and systematic reviews (2 papers). E Panak is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Lipoproteins and Cardiovascular Health (3 papers) and Meta-analysis and systematic reviews (2 papers). E Panak collaborates with scholars based in France, United States and Canada. E Panak's co-authors include J Blanchard, J. A. Blakely, J. Donald Easton, Michael Gent, V C Hachinski, Jane Sicurella, A. G. G. Turpie, Henry S. Sacks, Jean‐Claude Peyrieux and J.J. Thebault and has published in prestigious journals such as The Lancet, Stroke and Clinical Pharmacology & Therapeutics.

In The Last Decade

E Panak

13 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE

1989 616 citations Michael Gent, J. Donald Easton et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Panak France	10	702	330	317	277	247	14	1.1k
Basil A. Molony United States	6	609 0.9×	344 1.0×	221 0.7×	299 1.1×	242 1.0×	10	994
J. A. Blakely Canada	7	509 0.7×	324 1.0×	193 0.6×	255 0.9×	207 0.8×	9	804
Fúster United States	19	1.0k 1.5×	204 0.6×	445 1.4×	207 0.7×	171 0.7×	55	1.6k
J. Zahavi United Kingdom	19	471 0.7×	121 0.4×	333 1.1×	214 0.8×	296 1.2×	37	1.1k
Henry T. Lang United States	4	1.6k 2.2×	158 0.5×	889 2.8×	266 1.0×	191 0.8×	5	2.1k
J Boschat France	20	1.8k 2.6×	150 0.5×	882 2.8×	300 1.1×	152 0.6×	73	2.3k
Ernesto Paolasso Argentina	17	1.5k 2.2×	177 0.5×	469 1.5×	115 0.4×	329 1.3×	19	2.0k
Lawson McDonald United Kingdom	16	474 0.7×	161 0.5×	225 0.7×	200 0.7×	73 0.3×	32	1.0k
Henry DeMots United States	17	2.2k 3.1×	130 0.4×	921 2.9×	360 1.3×	289 1.2×	32	2.6k
Christine S. Zuern Germany	22	1.4k 2.0×	433 1.3×	467 1.5×	162 0.6×	171 0.7×	75	1.7k

Countries citing papers authored by E Panak

Since Specialization

Citations

This map shows the geographic impact of E Panak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Panak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Panak more than expected).

Fields of papers citing papers by E Panak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Panak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Panak. The network helps show where E Panak may publish in the future.

Co-authorship network of co-authors of E Panak

This figure shows the co-authorship network connecting the top 25 collaborators of E Panak. A scholar is included among the top collaborators of E Panak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Panak. E Panak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Verry, M., E Panak, & Jean‐Pierre Cazenave. (1994). Antiplatelet therapy in the prevention of ischaemic stroke.. PubMed. 36(3). 213–28. 6 indexed citations

2.

Panak, E, et al.. (1989). Ticlopidine in the Treatment of Peripheral Occlusive Arterial Disease. Seminars in Thrombosis and Hemostasis. 15(2). 167–170. 19 indexed citations

3.

Boissel, Jean‐Pierre, J Blanchard, E Panak, Jean‐Claude Peyrieux, & Henry S. Sacks. (1989). Considerations for the meta-analysis of randomized clinical trials. Controlled Clinical Trials. 10(3). 254–281. 91 indexed citations

4.

Gent, Michael, J. Donald Easton, V C Hachinski, et al.. (1989). THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE. The Lancet. 333(8649). 1215–1220. 616 indexed citations breakdown →

5.

Boissel, J. P., Henry S. Sacks, Alain Leizorovicz, et al.. (1988). Meta-analysis of clinical trials: Summary of an international conference. European Journal of Clinical Pharmacology. 34(6). 535–538. 21 indexed citations

6.

Blanchard, J, et al.. (1988). Multicenter Double-Blind Study of Ticlopidine in the Treatment of Intermittent Claudication and the Prevention of its Complications. Angiology. 39(9). 802–811. 77 indexed citations

7.

Gent, Michael, J. A. Blakely, J. Donald Easton, et al.. (1988). The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.. Stroke. 19(10). 1203–1210. 64 indexed citations

8.

Panak, E, et al.. (1984). Evaluation of the antithrombotic efficacy of ticlopidine in man.. PubMed. 15. 148–66. 5 indexed citations

9.

Panak, E, et al.. (1983). Ticlopidine: A Promise for the Prevention and Treatment of Thrombosis and Its Complications. Pathophysiology of Haemostasis and Thrombosis. 13(Suppl. 1). 1–54. 102 indexed citations

10.

Blatrix, C, et al.. (1982). A Possible Method to Control Prolongations of Bleeding Time under Antiplatelet Therapy with Ticlopidine. Thrombosis and Haemostasis. 48(1). 6–8. 19 indexed citations

11.

Thebault, J.J., et al.. (1975). Effects of ticlopidine, a new platelet aggregation inhibitor in man. Clinical Pharmacology & Therapeutics. 18(4). 485–490. 89 indexed citations

12.

Aubert, D., et al.. (1974). Athérogénèse expérimentale chez le rat wistar. Atherosclerosis. 20(2). 263–280. 8 indexed citations

13.

Blanchard, J, et al.. (1973). The Interactions of Ticlopidine and Aspirin in Normal Subjects. Journal of International Medical Research. 1(2). 405–411. 18 indexed citations

14.

Pasquier, Jennifer, et al.. (1970). The screening of atherosclerotic patients: A new epidemiological approach. Atherosclerosis. 12(2). 199–205.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact